Antibodies to Hepatitis C Virus in Chandigarh Blood Donors

Kumar, Sudarshan; Agnihotri, S. K.

doi:10.1046/j.1423-0410.1997.73402573.x

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The majority of the reported studies were among blood donors (103,(110)(111)(112)(113)(114)(115)(116)(117)(118)(119)(120)(121)(122)(123)(124), with rates ranging from 0.28 to 1.85%. The differences were attributed to different generations of the anti-HCV testing and differences in the populations and practices between different regions of the country (111-113, 117-119, 121).…”

Section: Prevalencementioning

confidence: 99%

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

Sievert

Altraif

Razavi

et al. 2011

Liver International

495

379

View full text Add to dashboard Cite

Background: The hepatitis C pandemic has been systematically studied and characterized in North America and Europe, but this important public health problem has not received equivalent attention in other regions. Aim: The objective of this systematic review was to characterize hepatitis C virus (HCV) epidemiology in selected countries of Asia, Australia and Egypt, i.e. in a geographical area inhabited by over 40% of the global population. Methodology: Data references were identified through indexed journals and non‐indexed sources. In this work, 7770 articles were reviewed and 690 were selected based on their relevance. Results: We estimated that 49.3–64.0 million adults in Asia, Australia and Egypt are anti‐HCV positive. China alone has more HCV infections than all of Europe or the Americas. While most countries had prevalence rates from 1 to 2% we documented several with relatively high prevalence rates, including Egypt (15%), Pakistan (4.7%) and Taiwan (4.4%). Nosocomial infection, blood transfusion (before screening) and injection drug use were identified as common risk factors in the region. Genotype 1 was common in Australia, China, Taiwan and other countries in North Asia, while genotype 6 was found in Vietnam and other Southeast Asian countries. In India and Pakistan genotype 3 was predominant, while genotype 4 was found in Middle Eastern countries such as Egypt, Saudi Arabia and Syria. Conclusion: We recommend implementation of surveillance systems to guide effective public health policy that may lead to the eventual curtailment of the spread of this pandemic infection.

show abstract

Section: Prevalencementioning

confidence: 99%

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

Sievert

Altraif

Razavi

et al. 2011

Liver International

495

379

View full text Add to dashboard Cite

show abstract

“…Hepatitis E virus (HEV) infection is the major cause of acute sporadic and epidemic hepatitis in India1234567891011. The frequency of hepatitis C has been reported to be 1-2 per cent among voluntary blood donors12131415. About 15-30 per cent cases of acute hepatitis in India is due to HBV1617, HCV is an uncommon cause of acute icteric hepatitis12 but causes most of the post-transfusion hepatitis12.…”

mentioning

confidence: 99%

Raise awareness of the global burden of viral hepatitis & to influence real change

Kar

2019

Indian Journal of Medical Research

View full text Add to dashboard Cite

Antibodies to Hepatitis C Virus in Chandigarh Blood Donors

Cited by 2 publications

References 3 publications

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt

Raise awareness of the global burden of viral hepatitis & to influence real change

Contact Info

Product

Resources

About